206 related articles for article (PubMed ID: 32491931)
1. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
Toshima H; Ogura I
Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
[TBL] [Abstract][Full Text] [Related]
2. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
3. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
Clin Radiol; 2020 Jan; 75(1):46-50. PubMed ID: 31699430
[TBL] [Abstract][Full Text] [Related]
5. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
6. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
Tezuka Y; Ogura I
Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies.
Modabber A; Schick D; Möhlhenrich SC; Mottaghy FM; Verburg FA; Hölzle F; Gerressen M
Eur J Radiol; 2020 Apr; 125():108917. PubMed ID: 32120276
[TBL] [Abstract][Full Text] [Related]
8. Maximum standardized uptake value of normal structures in the head and neck with bone SPECT/CT.
Tezuka Y; Ogura I
J Med Imaging Radiat Oncol; 2022 Oct; 66(7):936-939. PubMed ID: 34989162
[TBL] [Abstract][Full Text] [Related]
9. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
Ogawa R; Ogura I
Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
[TBL] [Abstract][Full Text] [Related]
11. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
Yfanti Z; Tetradis S; Nikitakis NG; Alexiou KE; Makris N; Angelopoulos C; Tsiklakis K
Eur J Radiol; 2023 Aug; 165():110916. PubMed ID: 37300936
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: Osteoradionecrosis versus medication-related osteonecrosis of the jaw.
Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
Imaging Sci Dent; 2019 Mar; 49(1):53-58. PubMed ID: 30941288
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
15. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
17. Comparison of single photon emission computed tomography-computed tomography, computed tomography and magnetic resonance imaging of medication-related osteonecrosis of jaw by new calculated parameters.
Minami Y; Ogura I
Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):126-132. PubMed ID: 36287042
[TBL] [Abstract][Full Text] [Related]
18. Vascular Analysis of Soft Tissues Around the Bone Lesion in Osteoradionecrosis, Medication-Related Osteonecrosis, and Infectious Osteomyelitis of the Jaw.
Wang Z; Xu J; Wan J; Zhang W; Wang Y; Du Y
J Craniofac Surg; 2022 Oct; 33(7):e750-e754. PubMed ID: 36201691
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.
Miyashita H; Kameyama K; Morita M; Nakagawa T; Nakahara T
Dentomaxillofac Radiol; 2019 Dec; 48(8):20190208. PubMed ID: 31287720
[TBL] [Abstract][Full Text] [Related]
20. Are Bacteria Just Bystanders in the Pathogenesis of Inflammatory Jaw Conditions?
He P; Francois K; Missaghian N; Le AD; Flynn TR; Shanti RM
J Oral Maxillofac Surg; 2022 Jun; 80(6):1094-1102. PubMed ID: 35405094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]